- |||||||||| MVX-ONCO-2 / MaxiVAX
Enrollment open, Trial completion date, Trial primary completion date: MVX-ONCO-2 in Advanced Solid Tumors (clinicaltrials.gov) - Oct 15, 2024
P1, N=6, Recruiting,
Withdrawn --> Recruiting | Trial completion date: Dec 2027 --> Oct 2029 | Trial primary completion date: Jul 2023 --> Oct 2025
- |||||||||| MVX-ONCO-2 / MaxiVAX
Trial withdrawal: MVX-ONCO-2 in Advanced Solid Tumors (clinicaltrials.gov) - Jan 30, 2023
P1, N=0, Withdrawn,
Withdrawn --> Recruiting | Trial completion date: Dec 2027 --> Oct 2029 | Trial primary completion date: Jul 2023 --> Oct 2025 Not yet recruiting --> Withdrawn
- |||||||||| MVX-ONCO-2 / MaxiVAX
Trial completion date, Trial initiation date, Trial primary completion date: MVX-ONCO-2 in Advanced Solid Tumors (clinicaltrials.gov) - Aug 24, 2022
P1, N=6, Not yet recruiting,
Not yet recruiting --> Withdrawn Trial completion date: May 2027 --> Dec 2027 | Initiation date: Mar 2022 --> Sep 2022 | Trial primary completion date: Dec 2022 --> Jul 2023
- |||||||||| MVX-ONCO-2 / MaxiVAX
Trial initiation date: MVX-ONCO-2 in Advanced Solid Tumors (clinicaltrials.gov) - Jan 27, 2022
P1, N=6, Not yet recruiting,
Trial completion date: May 2027 --> Dec 2027 | Initiation date: Mar 2022 --> Sep 2022 | Trial primary completion date: Dec 2022 --> Jul 2023 Initiation date: Nov 2021 --> Mar 2022
|
